| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41f348171d4db3451c79fee043df6cc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfdc6c4c6f51ef279e24d770923b4a11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c20c29b004bfa28feb279403183d1799
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_06729c9a2c0ff9e8796882d743d0dbe5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26d3a5de6abddb505902d165f7ee6d87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ace46170a1b4905c5ad2dddcb7ac3db |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-0606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C323-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C327-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-00 |
| filingDate |
2009-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3065ccadfc5d3e9ca3ec8a85f2463e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae6d94d1ac159ba75a13c76bc504b5b0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_150a39165108b7b923e556b996d961ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b439da023de83f462de2d387b2c93d25 |
| publicationDate |
2012-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8173809-B2 |
| titleOfInvention |
Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings |
| abstract |
The present invention provides cysteine and cystine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction. Exemplary prodrugs include the cysteine compound having the formula n nas well as cystine dimers thereof. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011224156-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9193681-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10961187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015045312-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10112897-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8815905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10358414-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9630937-B2 |
| priorityDate |
2008-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |